Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients stand to benefit.
Tag: Inventions and Patents
-
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
-
Will This Device Protect Athletes’ Brains, or Only Make Them Think It Does?
More and more pro and college athletes are trying on the Q-Collar as they search for something, anything, that might keep their brains safe. But does it work?
-
With Promise of Legalization, Psychedelic Companies Joust Over Future Profits
Cash rich start-ups are filing scores of patent claims on hallucinogens like magic mushrooms. Researchers and patient advocates worry high prices will make the therapies unaffordable.
-
MacArthur Foundation Announces 25 New ‘Genius’ Grant Winners
The 2022 awards are going to artists, activists, scholars, scientists and others who have shown “exceptional creativity.” The grants are a bit bigger than before: $800,000 over five years.